| Literature DB >> 19944071 |
Yukinari Kato1, Chien-Tsun Kuan, Jinli Chang, Mika Kato Kaneko, Joanne Ayriss, Hailan Piao, Vidyalakshmi Chandramohan, Charles Pegram, Roger E McLendon, Pam Fredman, Jan-Eric Månsson, Darell D Bigner.
Abstract
The lacto-series gangliosides 3'-isoLM1 and 3',6'-isoLD1 have been identified as tumor-associated antigens whose formation is initiated by the Lc3-synthase. Until now, high-affinity IgG monoclonal antibodies (mAbs) against 3'-isoLM1 and 3',6'-isoLD1, which are highly expressed in gliomas, have not been developed, although mAbs against lacto-series gangliosides are powerful tools for functional studies. We previously produced the Lc3-synthase gene beta3Gn-T5 knockout mice. In this study, we immunized beta3Gn-T5 knockout mice with 3'-isoLM1/3',6'-isoLD1 and produced the anti-3'-isoLM1/3',6'-isoLD1 mAb GMab-1, of the IgG(3) subclass, which should be useful for functional analysis of lacto-series gangliosides and for antibody-based therapy of gliomas. Copyright 2009 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19944071 PMCID: PMC2812581 DOI: 10.1016/j.bbrc.2009.11.132
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575